Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Directorate Change

6 Jun 2006 07:02

Synexus Clinical Research PLC06 June 2006 Synexus Clinical Research Plc ("the Company") Directorate change Synexus Clinical Research Plc is pleased to announce the appointment of MalcolmHughes (aged 52) as Non-Executive Director with immediate effect. Malcolm is currently Chief Executive of Greenman Group plc ("Greenman"), aprivate industrial company which supplies printer cartridges to European officesupplies distributors from its manufacturing base in Bulgaria. Prior toGreenman, he was Chief Executive of Oasis Healthcare Plc for four years duringwhich Oasis grew from a small regional business to become the leading dentalpractice owner/operator in the UK with turnover of over Β£70m. His previousexperience includes senior management roles at Chloride Group plc, LadbrokeGroup plc and Management Consulting Group plc. Commenting on the appointment, Michael Fort, chief executive of Synexus said : " I am delighted to welcome Malcolm to the Synexus board. He brings with himconsiderable knowledge and expertise, not only within the healthcare industrybut also particular experience of business operations within the emergingeconomies of Eastern Europe where Synexus has established a foothold and fromwhich we aim to expand rapidly. We look forward to benefiting from hiscontribution to the development and implementation of our growth strategy." Malcolm Hughes commented: "I am delighted to be joining Synexus at a time when it is seeking to build onits recent AIM flotation through expansion of its operations in the UK andinternationally. Its unique business model offers a strong proposition to globalpharmaceutical companies as they aim to develop more cost-effective methods oftrialling new drug treatments." Additional Information The following is a complete list of Mr Hughes' directorships as required underSchedule 2(g) of the AIM Rules: Current Previous in last 5 yearsGreenman Group plc Oasis Healthcare PlcGreenman UK Limited Oasis Dental Care LimitedGreenman Europe BV The Dencare Management Group LimitedK2 Supplies Limited Dencare Management LimitedPaprika Services Limited Dencare Financial Services LimitedBetforum UK Limited Dencare Developments Limited Dencare Implant Centres Limited Ora Dental Group Holdings Limited Ora Dental Group Limited Ora EBT Trustee Limited Inhoco 978 Limited Inhoco 979 Limited There is no further information required to be disclosed under Schedule 2(g) ofthe AIM Rules. For further information: Michael Fort, Chief Executive, Synexus Clinical Research PLC 01257 230 723 Zoe Biddick, Biddicks 020 7448 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Mar 20137:00 amRNSMajor Contract Win
27th Feb 20137:00 amRNSPreliminary Results
19th Feb 20137:00 amRNSIndanet Acquisition Renegotiation
15th Feb 20137:00 amRNSMajor Contract Win
8th Feb 20132:56 pmRNSHolding(s) in Company
28th Jan 20137:00 amRNSNotification of Preliminary Results
20th Dec 20127:00 amRNSYear End Trading Update
7th Dec 201212:41 pmRNSHolding(s) in Company
7th Nov 20123:30 pmRNSHolding(s) in Company
24th Oct 20127:00 amRNSTrading Update
10th Oct 20129:52 amRNSDirector/PDMR Shareholding
18th Sep 20122:04 pmRNSHolding(s) in Company
11th Sep 20125:10 pmRNSHolding(s) in Company
3rd Sep 20127:00 amRNSMajor £3m Contract for Complex Security System
14th Aug 20122:00 pmRNSHolding(s) in Company
13th Aug 20123:57 pmRNSHolding in Company
8th Aug 20121:36 pmRNSDirector/PDMR Shareholding
25th Jul 20127:00 amRNSInterim Results
16th Jul 20121:02 pmRNSChange of Name to Synectics plc
3rd Jul 20127:00 amRNSHolding(s) in Company
19th Jun 20127:00 amRNSNotification of Interim Results
18th May 20129:51 amRNSDirector/PDMR Shareholding
3rd May 20122:45 pmRNSHolding(s) in Company
2nd May 201211:57 amRNSResult of AGM
23rd Apr 20122:58 pmRNSDirector/PDMR Shareholding
19th Apr 201212:42 pmRNSDirector/PDMR Shareholding
13th Apr 20127:00 amRNSAdditional Listing
2nd Apr 20127:00 amRNS£7million, 6 Year Contract Win
29th Mar 201210:46 amRNSAvailability of Report & Accounts
13th Mar 20129:49 amRNSHolding(s) in Company
13th Mar 20129:26 amRNSHolding(s) in Company
9th Mar 20123:56 pmRNSHolding(s) in Company
8th Mar 20125:02 pmRNSHolding(s) in Company
1st Mar 20127:01 amRNSMajor Contract Awards
1st Mar 20127:00 amRNSPreliminary Results
20th Feb 20121:35 pmRNSHolding(s) in Company
6th Feb 20127:00 amRNSNotification of Preliminary Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
29th Dec 201110:59 amRNSDirector/PDMR Shareholding
10th Nov 20112:41 pmRNSHolding(s) in Company
3rd Nov 20114:10 pmRNSHolding(s) in Company
1st Nov 20113:52 pmRNSDirector/PDMR Shareholding
25th Oct 20112:33 pmRNSHolding(s) in Company
11th Oct 201112:40 pmRNSHolding(s) in Company
19th Jul 20113:49 pmRNSHolding(s) in Company
18th Jul 20117:00 amRNSAcquisition of Indanet AG
8th Jun 20112:41 pmRNSHolding(s) in Company
26th May 20117:00 amRNSHolding(s) in Company
19th May 20113:28 pmRNSReplacement - Holding(s) in Company
19th May 201110:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.